Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

Novavax Stock Up on Swiss Approval of Nuvaxovid

By Will Ashworth, InvestorPlace Contributor

Novavax’s Covid-19 vaccine Nuvaxovid just got approved for in Switzerland. NVAX stock is up on news. It couldn’t have come at a better time. 

Alphabet Stock Should Benefit From 2022 U.S. Spending

By Will Ashworth, InvestorPlace Contributor

Alphabet CEO Sundar Pichai announced on April 13 that it would invest $9.5 billion in the U.S. in 2022. Job creation is good for GOOG stock. 

Picking Your Spot Remains Elusive for the SPDR S&P 500 ETF Trust 

By Will Ashworth, InvestorPlace Contributor

The SPDR S&P 500 ETF Trust lost 1.7% on April 11. It is now down almost 8% year-to-date. SPY stock continues to struggle to stay above $450.   

Shiba Inu Just Laid an Egg With Its Metaverse Land Sales

By Will Ashworth, InvestorPlace Contributor

Shiba Inu was supposed to launch the initial sale of plots of land for its Metaverse. That hasn't happened as planned. Investors be wary.

C3.ai Is About to Have its Feet Held to the Fire

By Will Ashworth, InvestorPlace Contributor

C3.ai faces a class-action lawsuit regarding potentially misleading statements in its IPO documents. That’s not good news for AI stock.  

Load More